title: Masked hypertension unfavourably affects haemostasis parameters.
abstract: OBJECTIVE. Recent evidence demonstrates that masked hypertension (MH) is a significant predictor of cardiovascular disease. The aim of our study was to examine the impact of MH on haemostasis parameters and to compare the findings to those of healthy normotensives matched for age, sex, body mass index and the rest of risk factors. DESIGN AND METHOD. 130 (60 male, 70 female) healthy subjects mean age 45 ± 12 years who had clinic blood pressure < 140/90 mmHg were studied. The whole study population underwent 24-h ambulatory blood pressure monitoring (ABPM). According to the ABPM recordings, 24 individuals (eight males, 16 females) had MH (daytime systolic blood pressure ≥ 135 mmHg or daytime diastolic blood pressure ≥ 85 mmHg - group A) and the remaining 106 subjects (52 males, 54 females) had normal ABPM recordings - group B. Fibrinogen, thrombomodulin ™, the antigens of plasminogen activator inhibitor 1 (PAI-1Ag) and tissue plasminogen activator (tPA-Ag) were determined in the two groups. Results. The PAI-1 Ag, tPA-Ag, fibrinogen and TM levels were significantly higher in the masked hypertensive group than to normotensive control group. CONCLUSIONS. Our findings suggest that subjects with MH have significantly higher fibrinogen, TM, PAI-1Ag and tPA-Ag plasma levels compared with normotensives. This observation may have prognostic significance for future cardiovascular events in subjects with MH and needs further investigation.
authors.affiliation: ESH Excellent Center of Hypertension, Laiko Univesity Hospital, Athens, Greece. jimpapdoc@yahoo.com
authors.forename: D P
authors.initials: DP
authors.lastname: Papadopoulos
authors.forename: C
authors.initials: C
authors.lastname: Thomopoulos
authors.forename: I
authors.initials: I
authors.lastname: Mourouzis
authors.forename: A
authors.initials: A
authors.lastname: Kotrotsou
authors.forename: E
authors.initials: E
authors.lastname: Sanidas
authors.forename: U
authors.initials: U
authors.lastname: Papazachou
authors.forename: M
authors.initials: M
authors.lastname: Daskalaki
authors.forename: T K
authors.initials: TK
authors.lastname: Makris
mesh_terms: D000941:Antigens / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology; D015331:Cohort Studies; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006487:Hemostasis; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000276:immunology; D018180:Thrombomodulin / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000276:immunology
chemical_list: D000941:Antigens; D017395:Plasminogen Activator Inhibitor 1; C546931:THBD protein, human; D018180:Thrombomodulin; D005340:Fibrinogen; D010959:Tissue Plasminogen Activator